Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke
Completed
Phase 3 ResultsView Trial Locations
Recruitment
- Enrollment: 720
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 12 locations, 1 country
Principal Investigator
- Yi N Huang, Professor
Peking University First Hospital